Valuation: AbbVie Inc.

Market Cap 449B 393B 363B 339B 638B 42,480B 653B 4,371B 1,687B 20,957B 1,687B 1,650B 72,760B P/E 2026 *
31.4x
P/E 2027 * 23.8x
Enterprise Value 505B 442B 408B 381B 718B 47,756B 734B 4,913B 1,897B 23,560B 1,897B 1,855B 81,798B EV / Sales 2026 *
7.51x
EV / Sales 2027 * 6.81x
Free-Float
95.71%
Yield 2026 *
2.72%
Yield 2027 * 2.84%
1 day-0.17%
1 week+10.56%
Current month+16.81%
1 month+16.81%
3 months+21.45%
6 months+10.17%
Current year+11.30%
1 week 232.85
Extreme 232.85
255.99
1 month 208.99
Extreme 208.99
255.99
Current year 190.75
Extreme 190.75
255.99
1 year 184.38
Extreme 184.385
255.99
3 years 132.7
Extreme 132.7
255.99
5 years 105.56
Extreme 105.56
255.99
10 years 55.06
Extreme 55.0623
255.99
Manager TitleAgeSince
Chief Executive Officer 55 2024-06-30
Director of Finance/CFO 59 2022-06-22
Chief Tech/Sci/R&D Officer - 2024-02-29
Director TitleAgeSince
Director/Board Member 65 2012-12-31
Director/Board Member 74 2012-12-31
Director/Board Member 68 2012-12-31
Date Insider Type Main position Quantity % Market Cap.
05-07Free

Director

1,118 0.0001%
05-07Free

Director

1,118 0.0001%
05-07Free

Director

1,118 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.38%+10.56%+39.49%+90.88% 449B
+1.81%+11.60%+58.61%+164.79% 1,097B
+1.51%+11.77%+69.61%+57.53% 622B
-0.87%+6.34%+29.51%+24.01% 334B
+0.43%+5.74%+42.00%+27.44% 294B
+0.98%+3.13%+32.35%+41.42% 286B
+1.07%+3.62%-27.46%-41.99% 213B
+0.62%+4.59%+30.10%+63.03% 195B
-1.21%+1.17%+14.15%+66.20% 157B
+0.33%-2.83%+0.74%-32.53% 139B
Average +0.18%+5.74%+28.91%+46.08% 378.56B
Weighted average by Cap. +0.24%+8.26%+42.03%+77.79%

Financials

2026 *2027 *
Net sales 67.24B 58.87B 54.35B 50.75B 95.54B 6,357B 97.72B 654B 252B 3,136B 253B 247B 10,888B 72.73B 63.68B 58.79B 54.9B 103B 6,876B 106B 707B 273B 3,392B 273B 267B 11,778B
Net income 14.56B 12.75B 11.77B 10.99B 20.69B 1,377B 21.16B 142B 54.68B 679B 54.68B 53.48B 2,358B 19.02B 16.66B 15.38B 14.36B 27.03B 1,799B 27.65B 185B 71.44B 887B 71.44B 69.87B 3,081B
Net Debt 55.81B 48.87B 45.11B 42.13B 79.3B 5,276B 81.11B 543B 210B 2,603B 210B 205B 9,038B 46.34B 40.57B 37.45B 34.98B 65.84B 4,381B 67.34B 451B 174B 2,161B 174B 170B 7,503B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
26-06-29 US$254.31 +0.38% 9,760,531
26-06-26 US$253.35 +4.20% 52,635,078
26-06-25 US$243.14 +3.51% 10,281,847
26-06-24 US$234.89 +0.06% 7,311,033
26-06-23 US$234.76 +2.07% 7,366,040
Trader
Investor
Global
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
254.31USD
Average target price
256.14USD
Spread / Average Target
+0.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock